0001354457-13-000173.txt : 20130820
0001354457-13-000173.hdr.sgml : 20130820
20130820153422
ACCESSION NUMBER: 0001354457-13-000173
CONFORMED SUBMISSION TYPE: 25-NSE
CONFIRMING COPY:
PUBLIC DOCUMENT COUNT: 2
FILED AS OF DATE: 20130820
DATE AS OF CHANGE: 20130820
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: PURE BIOSCIENCE, INC.
CENTRAL INDEX KEY: 0001006028
STANDARD INDUSTRIAL CLASSIFICATION: MISCELLANEOUS CHEMICAL PRODUCTS [2890]
IRS NUMBER: 330530289
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0731
FILING VALUES:
FORM TYPE: 25-NSE
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14468
BUSINESS ADDRESS:
STREET 1: 1725 GILLESPIE WAY
CITY: EL CAJON
STATE: CA
ZIP: 92020
BUSINESS PHONE: 619-596-8600
MAIL ADDRESS:
STREET 1: 1725 GILLESPIE WAY
CITY: EL CAJON
STATE: CA
ZIP: 92020
FORMER COMPANY:
FORMER CONFORMED NAME: PURE BIOSCIENCE
DATE OF NAME CHANGE: 20031029
FORMER COMPANY:
FORMER CONFORMED NAME: PURE BIOSCIENCES
DATE OF NAME CHANGE: 20031029
FORMER COMPANY:
FORMER CONFORMED NAME: INNOVATIVE MEDICAL SERVICES
DATE OF NAME CHANGE: 19960122
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: NASDAQ Stock Market LLC
CENTRAL INDEX KEY: 0001354457
IRS NUMBER: 521165937
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 25-NSE
BUSINESS ADDRESS:
STREET 1: 9600 BLACKWELL RD
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
BUSINESS PHONE: 301-978-4144
MAIL ADDRESS:
STREET 1: 9600 BLACKWELL RD
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
25-NSE
1
primary_doc.xml
X0203
0001354457
NASDAQ Stock Market LLC
0001006028
PURE BIOSCIENCE, INC.
001-14468
1725 Gillespie Way
El Cajon
CA
CALIFORNIA
92020
+1 619 596-8600
Common stock
17 CFR 240.12d2-2(b)
Amy Horton
Associate General Counsel
2013-08-20
EX-99.25
2
puredelistreason.txt
Delisting Determination,The Nasdaq Stock Market, LLC,
August 20, 2013, PURE Bioscience, Inc.
The Nasdaq Stock Market, Inc. (the Exchange) has determined
to remove from listing the common stock of PURE Bioscience, Inc.
(the Company), effective at the opening of the trading
session on August 30, 2013. Based on review of information
provided by the Company, Nasdaq Staff determined that the
Company no longer qualified for listing on the Exchange
pursuant to Listing Rule 5550(b)(1).
The Company was notified of the Staffs
determination on March 4, 2013. The Company appealed
the determination to a Hearing Panel.
Upon review of the information provided by the Company,
the Panel issued a decision dated April 24, 2013, granting
the Company continued listing pursuant to an exception
through June 18, 2013, by which date the Company was
required to regain compliance with Listing Rule 5550(b)(1).
However, the Company did not regain compliance
by that date. On May 15, 2013,
the Panel issued a final delisting determination and
notified the Company that trading in the Companys
securities would be suspended on May 17, 2013.
The Company did not request a review of the Panels decision
by the Nasdaq Listing and Hearing Review Council. The
Listing Council did not call the matter for review.
The Panels Determination to delist the Company became
final on July 1, 2013.